Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6776)
All Articles published online
|
Publishing Process of This Article
|
Dec 14, 2015 (publication date) through May 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lei YC, Yang LL, Li W, Luo P, Zheng PF. Inhibition of sphingosine kinase 1 ameliorates acute liver failure by reducing high-mobility group box 1 cytoplasmic translocation in liver cells. World J Gastroenterol 2015; 21(46): 13055-13063 [PMID: 26676341 DOI: 10.3748/wjg.v21.i46.13055] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i46/13055.htm |
| Number | Citing Articles |
| 1 |
Timothy Rohrbach, Michael Maceyka, Sarah Spiegel. Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology. Critical Reviews in Biochemistry and Molecular Biology 2017; 52(5): 543 doi: 10.1080/10409238.2017.1337706
|
| 2 |
Runkuan Yang, Shengtao Zhu, Soeren Erik Pischke, Hakon Haugaa, Xiaoping Zou, Tor Inge Tonnessen. Bile and circulating HMGB1 contributes to systemic inflammation in obstructive jaundice. Journal of Surgical Research 2018; 228: 14 doi: 10.1016/j.jss.2018.02.049
|
| 3 |
Zi-Shen Zhou, Chen-Fan Kong, Jian-Rong Sun, Xiang-Ke Qu, Jin-Hui Sun, An-Tao Sun. Fisetin Ameliorates Alcohol-Induced Liver Injury through Regulating SIRT1 and SphK1 Pathway. The American Journal of Chinese Medicine 2022; 50(08): 2171 doi: 10.1142/S0192415X22500938
|
| 4 |
Olga A. Sukocheva, Margarita E. Neganova, Yulia Aleksandrova, Jack T. Burcher, Elena Chugunova, Ruitai Fan, Edmund Tse, Gautam Sethi, Anupam Bishayee, Junqi Liu. Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-024-01626-6
|
| 5 |
Dorit Avni, Kuzhuvelil B. Harikumar, Arun J. Sanyal, Sarah Spiegel. Deletion or inhibition of SphK1 mitigates fulminant hepatic failure by suppressing TNFα‐dependent inflammation and apoptosis. The FASEB Journal 2021; 35(3) doi: 10.1096/fj.202002540R
|
| 6 |
Wei Chao-shun, Wang Xiao-Li. The impacts of SphK1 on inflammatory response and oxidative stress in LPS-induced ALI/ARDS. European Journal of Inflammation 2023; 21: 1721727X2311583 doi: 10.1177/1721727X231158310
|
| 7 |
Jinfeng Yu, Jiale Dong, Kangdi Chen, Yaping Ding, Zhicheng Yang, Tian Lan. Generation of mice with hepatocyte-specific conditional deletion of sphingosine kinase 1. Transgenic Research 2020; 29(4): 419 doi: 10.1007/s11248-020-00211-0
|
| 8 |
Runkuan Yang, Xiaoping Zou, Jyrki Tenhunen, Tor Inge Tønnessen. HMGB1 and Extracellular Histones Significantly Contribute to Systemic Inflammation and Multiple Organ Failure in Acute Liver Failure. Mediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/5928078
|
| 9 |
Tao Tian, Danhua Yao, Lei Zheng, Zhiyuan Zhou, Yantao Duan, Bin Liu, Pengfei Wang, Yousheng Li. Sphingosine kinase 1 regulates HMGB1 translocation by directly interacting with calcium/calmodulin protein kinase II-δ in sepsis-associated liver injury. Cell Death & Disease 2020; 11(12) doi: 10.1038/s41419-020-03255-6
|
| 10 |
Tao Tian, Weiliang Tian, Fan Yang, Risheng Zhao, Qian Huang, Yunzhao Zhao. Sphingosine kinase 1 inhibition improves lipopolysaccharide/D‐galactosamine‐induced acute liver failure by inhibiting mitogen‐activated protein kinases pathway. United European Gastroenterology Journal 2016; 4(5): 677 doi: 10.1177/2050640616637968
|
| 11 |
Yuval Ishay, Dean Nachman, Tawfik Khoury, Yaron Ilan. The role of the sphingolipid pathway in liver fibrosis: an emerging new potential target for novel therapies. American Journal of Physiology-Cell Physiology 2020; 318(6): C1055 doi: 10.1152/ajpcell.00003.2020
|
| 12 |
Zhiyang Chen, min Hu. The apoM-S1P axis in hepatic diseases. Clinica Chimica Acta 2020; 511: 235 doi: 10.1016/j.cca.2020.10.023
|
| 13 |
Runkuan Yang, Tor Inge Tonnesseen. DAMPs and sterile inflammation in drug hepatotoxicity. Hepatology International 2019; 13(1): 42 doi: 10.1007/s12072-018-9911-9
|
| 14 |
Lidan Luo, Shuai Wang, Bohao Chen, Mei Zhong, Ruili Du, ChunShan Wei, Furong Huang, Xinhui Kou, Yufeng Xing, Guangdong Tong. Inhibition of inflammatory liver injury by the HMGB1-A box through HMGB1/TLR-4/NF-κB signaling in an acute liver failure mouse model. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.990087
|
| 15 |
Yuval Ishay, Dvorah Rotnemer-Golinkin, Yaron Ilan. The role of the sphingosine axis in immune regulation: A dichotomy in the anti-inflammatory effects between sphingosine kinase 1 and sphingosine kinase 2-dependent pathways. International Journal of Immunopathology and Pharmacology 2021; 35: 205873842110532 doi: 10.1177/20587384211053274
|
| 16 |
Kyu Min Kim, Eun Jin Shin, Ji Hye Yang, Sung Hwan Ki. Integrative roles of sphingosine kinase in liver pathophysiology. Toxicological Research 2023; 39(4): 549 doi: 10.1007/s43188-023-00193-1
|